•
Sep 30, 2024
Bruker Q3 2024 Earnings Report
Bruker reported Q3 2024 financial results with revenue up 16.4% year-over-year and organic revenue up 3.1%.
Key Takeaways
Bruker reported Q3 2024 revenues of $864.4 million, a 16.4% increase year-over-year. GAAP diluted EPS was $0.27, and non-GAAP diluted EPS was $0.60. The company updated its FY2024 guidance, expecting revenues of $3.34 to $3.37 billion and non-GAAP EPS of $2.36 to $2.41.
Q3 2024 revenues reached $864.4 million, a 16.4% increase year-over-year.
Bruker organic revenue grew by 3.1% year-over-year.
GAAP diluted EPS was $0.27, while non-GAAP diluted EPS was $0.60.
FY2024 revenue is projected to be $3.34 to $3.37 billion, with organic revenue growth of 3% to 4%.
Bruker
Bruker
Forward Guidance
Bruker expects FY2024 revenues of $3.34 to $3.37 billion, with organic revenue growth of 3% to 4%, and non-GAAP EPS of $2.36 to $2.41.
Positive Outlook
- Revenue between $3.34 and $3.37 billion.
- Organic revenue growth of 3% to 4%.
- Contribution from M&A approximately 9.5%.
- CER revenue growth of approximately 13%.
- Non-GAAP EPS of $2.36 - $2.41